Location: | London |
---|---|
Salary: | £37,889 to £45,974 per annum |
Hours: | Full Time |
Contract Type: | Fixed-Term/Contract |
Placed On: | 11th June 2025 |
---|---|
Closes: | 2nd July 2025 |
Job Ref: | 6074 |
About the Role
We are seeking a researcher for a new programme focused on improving understanding of cancer risk and developing novel multicancer risk prediction models to support cancer prevention and early detection interventions. This role is part of the Cancer Research UK funded CD3 programme, a new multidisciplinary and multi-institutional strategic national research initiative dedicated to using data to revolutionise our understanding of cancer risk and enable early interception of cancers (Queen Mary media & Cancer Research UK News). You will use large primary care and other diverse healthcare datasets to identify novel cancer risk factors, develop prediction models to provide individualised cancer risk using cutting edge methods, and examine the impact of exemplar interventions on risk reduction. You will be supported by a multidisciplinary internationally renowned team from within QMUL and the wider CD3 community which has expertise in health data science, risk prediction, statistics, AI and clinical practice.
About You
Applicants should have a PhD (or be close to completion) or research qualification/experience equivalent to PhD level in the relevant subject area. Experience conducting quantitative research using large healthcare datasets, experience working successfully in multi-disciplinary teams and an interest in clinical risk prediction is essential. Applicants should also have experience using statistical packages such as Stata, R or Python.
About the Institute
The Wolfson Institute of Population Health (WIPH) is an exciting and dynamic environment, home to more than 450 staff, 100 PhD students and c500 postgraduate taught students. It harnesses expertise across a wide range of population-based research and education activities and aims to be an internationally recognised centre of excellence in population health, primary care and preventive medicine. The Institute is organised into six separate research centres which, though complementary and following the Institute strategic plan, also have Centre-specific objectives and requirements.
The Centre for Cancer Screening, Prevention and Early Diagnosis forms part of the WIPH and brings together globally leading researchers focusing on cancer prevention, cancer screening and detection and early diagnosis across three units including the CRUK-funded Cancer Prevention Trials Unit. CCSPED also hosts the cross-cutting Cancer Behavioural Science group.
About Queen Mary
At Queen Mary University of London, we believe that a diversity of ideas helps us achieve the previously unthinkable.
Throughout our history, we’ve fostered social justice and improved lives through academic excellence. And we continue to live and breathe this spirit today, not because it’s simply ‘the right thing to do’ but for what it helps us achieve and the intellectual brilliance it delivers.
We continue to embrace diversity of thought and opinion in everything we do, in the belief that when views collide, disciplines interact, and perspectives intersect, truly original thought takes form.
Benefits
We offer competitive salaries, access to a generous pension scheme, 30 days’ leave per annum (pro-rata for part-time/fixed term), a season ticket loan scheme and access to a comprehensive range of personal and professional development opportunities. In addition, we offer a range of work life balance and family friendly, inclusive employment policies, flexible working arrangements, and campus facilities.
Queen Mary’s commitment to our diverse and inclusive community is embedded in our appointments processes. Reasonable adjustments will be made at each stage of the recruitment process for any candidate with a disability. We are open to considering applications from candidates wishing to work flexibly.
Type / Role:
Subject Area(s):
Location(s):